Jean Lud Cadet
Senior Investigator
Molecular Neuropsychiatry Research Branch
National Institute on Drug Abuse
United States of America
Biography
M.D. - Columbia University College of Physicians and Surgeons Residencies - Department of Psychiatry at Columbia University College of Physicians and Surgeons - Department of Neurology at Mount Sinai Medical Center in NYC Post-Doctoral Fellowship - Neuropsychiatry Branch, NIMH
Research Interest
Research in our section focuses on studies the molecular and cellular mechanisms of psychostimulant addiction and toxicity. Dr. Cadet’s group has provided recent evidence that methamphetamine (METH) self-administration is accompanied with markers of toxicity in striatal dopaminergic systems. These results are consistent with the idea that catecholamines, especially, dopamine can activate neurodegenerative processes in the mammalian brain. We have also shown recently that METH preconditioning protects against METH toxicity. This occurs by upregulation of neurotrophic factors such as BDNF and/or downregulation of glutamatergic systems. Preliminary studies have shown that these changes are secondary to epigenetic modifications that include histone hypoacetylation and DNA methylation. The laboratory is thus pursuing investigations to further identify epigenetic markers that are involved in METH self-administration and METH preconditioning.